Literature DB >> 17524875

Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients.

H Khedmat1, M Ahmadzad-Asl, M Amini, M Lessan-Pezeshki, B Einollahi, V Pourfarziani, M H Naseri, F Davoudi.   

Abstract

BACKGROUND: Upper gastrointestinal (UGI) symptoms are common in uremic patients, and higher serum levels of urea have been suggested to be related to Helicobacter pylori (HP) colonization and UGI mucosal inflammation. AIM: The aim of this study was to compare HP infection and UGI endoscopic findings between uremic patients, renal transplant (RT) recipients, and controls.
METHODS: A total of 474 subjects (71 chronic renal failure [CRF], 73 hemodialysis [HD], 25 Tx, and 305 controls) from Baqyiatallah Hospital, Tehran, Iran were recruited between April 2002 and March 2004 for evaluation of dyspepsia, excluding those receiving any HP-eradication therapy. All subjects were examined for esophagus, stomach and duodenum mucosa, and infection with HP on 2 distinct tissue samples of the anthral region.
RESULTS: Four groups of subjects (mean +/- 2 se; age, 45 +/- 1.6 years; 62.9% male) were studied. Duodenal ulcer in the uremic patients (CRF, 16.1%; HD, 13.7%) was more common than that in the RT-recipients (8%) and controls (6.5%); P=.038. Erosive gastritis and duodenal bulb deformity were also more common in the uremic subjects (CRF, 23.9%, 36.9%; HD, 30.1%, 20.5%, respectively) than those in the other subjects (RT recipients, 16%, 8%; controls, 8.2%; 0%, respectively); P<.001. HP infection was found to be higher in the uremic patients (CRF, 66.2%; HD, 63%) than in the RT recipients (40%) and controls (34.8%); P<.001.
CONCLUSION: Higher rates of gastric and duodenal mucosal lesions and HP infection in the uremic patients in comparison with the subjects with normal renal function may have resulted from higher serum levels of urea, anemia, and fluctuations in the gastric blood supply in the CRF and HD patients. However, more tenable evidence from controlled trials is required for the eradication of HP in all uremic patients and transplantation candidates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17524875     DOI: 10.1016/j.transproceed.2007.03.034

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  23 in total

Review 1.  Review of Helicobacter pylori infection and chronic renal failure.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Ther Apher Dial       Date:  2010-08-31       Impact factor: 1.762

Review 2.  Association of Helicobacter pylori with Chronic Kidney Diseases: A Meta-Analysis.

Authors:  Karn Wijarnpreecha; Charat Thongprayoon; Pitchaphon Nissaisorakarn; Veeravich Jaruvongvanich; Kiran Nakkala; Ridhmi Rajapakse; Wisit Cheungpasitporn
Journal:  Dig Dis Sci       Date:  2017-03-06       Impact factor: 3.199

3.  Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients.

Authors:  Ju-Yeh Yang; Tsung-Chun Lee; Maria E Montez-Rath; Jane Paik; Glenn M Chertow; Manisha Desai; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

4.  Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis.

Authors:  Jiing-Chyuan Luo; Hsin-Bang Leu; Kuang-Wei Huang; Chin-Chou Huang; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Shou-Dong Lee
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

Review 5.  Gastrointestinal disorders and renal failure: exploring the connection.

Authors:  Shayan Shirazian; Jai Radhakrishnan
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

6.  Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis.

Authors:  Tomohiko Moriyama; Takayuki Matsumoto; Katsuya Hirakawa; Hirofumi Ikeda; Kazuhiko Tsuruya; Hideki Hirakata; Mitsuo Iida
Journal:  J Gastroenterol       Date:  2010-01-19       Impact factor: 7.527

7.  Prevalence of Helicobacter pylori infection in long-term hemodialysis patients.

Authors:  Mitsushige Sugimoto; Kyoko Sakai; Masakazu Kita; Jiro Imanishi; Yoshio Yamaoka
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

8.  Comparison of azithromycin and clarithromycin triple therapy regimens for helicobacter pylori eradication in hemodialysis patients.

Authors:  Mojgan Jalalzadeh; Morteza Nazarian; Jamshid Vafaeimanesh; Fatemeh Mirzamohammadi
Journal:  Nephrourol Mon       Date:  2012-06-20

Review 9.  Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

10.  Decisive indicator for gastrointestinal workup in anemic patients with nondialysis chronic kidney disease.

Authors:  Hyeon Seok Hwang; Youn Mi Song; Eun Oh Kim; Eun Sil Koh; Hye Eun Yoon; Sung Jin Chung; Sang Ju Lee; Yoon Kyung Chang; Chul Woo Yang; Yoon Sik Chang; Suk Young Kim
Journal:  Int J Med Sci       Date:  2012-09-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.